Therapeutic potential of targeting enhanced O-GlcNAcylation in malignant mesothelioma with disrupted Hippo pathway

Mukai, S; Sato, T; Mishiro, E; Aoki, M; Yabuta, N; Sekido, Y

CANCER SCIENCE, 2023; 114 (): 2057